UTAH MEDICAL PRODUCTS, INC. Cash and Cash Equivalents, Period Increase (Decrease)
UTAH MEDICAL PRODUCTS, INC. (UTMD) reported Cash and Cash Equivalents, Period Increase (Decrease) of -$3.17 million for the 3-month period ending 2020-03-31, per its 10-Q filed 2020-05-08.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashAndCashEquivalentsPeriodIncreaseDecrease · last filed 2020-05-08
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2020-03-31 was -$3.17M.
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-12-31 was $5.39M, a 206.48% increase year-over-year.
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-09-30 was $4.51M, a 29.72% increase year-over-year.
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for the quarter ending 2019-06-30 was $215.00K, a 92.88% decline year-over-year.
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2019 was -$8.32M, a 174.09% decline from fiscal 2018.
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2018 was $11.24M, a 17.25% decline from fiscal 2017.
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2017 was $13.58M, a 349.93% increase from fiscal 2016.
- UTAH MEDICAL PRODUCTS, INC. cash and cash equivalents, period increase (decrease) for fiscal 2016 was $3.02M, a 24.63% decline from fiscal 2015.
| Period end | Cash and Cash Equivalents, Period Increase (Decrease) 3 month | Cash and Cash Equivalents, Period Increase (Decrease) 6 month | Cash and Cash Equivalents, Period Increase (Decrease) 9 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month | Cash and Cash Equivalents, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2020-03-31 | -$3.17M 10-Q · filed 2020-05-08 | $2.22M derived: sum of 2 quarters · filed 2020-05-08 | $6.73M derived: sum of 3 quarters · filed 2020-05-08 | $6.95M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2019-12-31 | $5.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $9.91M derived: sum of 2 quarters · filed 2020-03-16 | $10.12M derived: sum of 3 quarters · filed 2020-03-16 | -$8.32M 10-K · filed 2020-03-16 | |
| 2019-09-30 | $4.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $4.73M derived: sum of 2 quarters · filed 2019-11-07 | -$13.72M 10-Q · filed 2019-11-07 | -$11.96M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2019-06-30 | $215.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$18.23M 10-Q · filed 2019-08-09 | -$16.47M derived: sum of 3 quarters · filed 2020-05-08 | -$12.99M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2019-03-31 | -$18.45M 10-Q · filed 2020-05-08 | -$16.69M derived: sum of 2 quarters · filed 2020-05-08 | -$13.21M derived: sum of 3 quarters · filed 2020-05-08 | -$10.19M derived: sum of 4 quarters · filed 2020-05-08 | |
| 2018-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $5.24M derived: sum of 2 quarters · filed 2020-03-16 | $8.26M derived: sum of 3 quarters · filed 2020-03-16 | $11.24M 10-K · filed 2020-03-16 | |
| 2018-09-30 | $3.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | $6.50M derived: sum of 2 quarters · filed 2019-11-07 | $9.48M 10-Q · filed 2019-11-07 | $11.91M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-06-30 | $3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $6.00M 10-Q · filed 2019-08-09 | $8.44M derived: sum of 3 quarters · filed 2020-03-16 | $12.14M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2018-03-31 | $2.98M 10-Q · filed 2019-05-09 | $5.42M derived: sum of 2 quarters · filed 2020-03-16 | $9.12M derived: sum of 3 quarters · filed 2020-03-16 | $12.17M derived: sum of 4 quarters · filed 2020-03-16 | |
| 2017-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-16 | $6.14M derived: sum of 2 quarters · filed 2020-03-16 | $9.20M derived: sum of 3 quarters · filed 2020-03-16 | $13.58M 10-K · filed 2020-03-16 | |
| 2017-09-30 | $3.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $6.76M derived: sum of 2 quarters · filed 2018-11-07 | $11.14M 10-Q · filed 2018-11-07 | $5.88M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | $3.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $7.44M 10-Q · filed 2018-08-09 | $2.18M derived: sum of 3 quarters · filed 2019-03-14 | $4.34M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | $4.38M 10-Q · filed 2018-05-09 | -$877.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.28M derived: sum of 3 quarters · filed 2019-03-14 | $3.16M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | -$5.26M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$3.10M derived: sum of 2 quarters · filed 2019-03-14 | -$1.22M derived: sum of 3 quarters · filed 2019-03-14 | $3.02M 10-K · filed 2019-03-14 | |
| 2016-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $4.04M derived: sum of 2 quarters · filed 2017-11-07 | $8.28M 10-Q · filed 2017-11-07 | $9.93M derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-06-30 | $1.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-03 | $6.12M 10-Q · filed 2017-08-03 | $7.77M derived: sum of 3 quarters · filed 2018-03-06 | $10.23M derived: sum of 4 quarters · filed 2018-03-06 | |
| 2016-03-31 | $4.24M 10-Q · filed 2017-05-05 | $5.89M derived: sum of 2 quarters · filed 2018-03-06 | $8.35M derived: sum of 3 quarters · filed 2018-03-06 | $11.41M derived: sum of 4 quarters · filed 2018-03-06 | |
| 2015-12-31 | $1.66M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-06 | $4.11M derived: sum of 2 quarters · filed 2018-03-06 | $7.18M derived: sum of 3 quarters · filed 2018-03-06 | $4.00M 10-K · filed 2018-03-06 | |
| 2015-09-30 | $2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $5.52M derived: sum of 2 quarters · filed 2016-11-04 | $2.35M 10-Q · filed 2016-11-04 | $3.37M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-06-30 | $3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$105.00K 10-Q · filed 2016-08-08 | $921.00K derived: sum of 3 quarters · filed 2017-03-08 | $3.23M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2015-03-31 | -$3.17M 10-Q · filed 2016-05-06 | -$2.15M derived: sum of 2 quarters · filed 2017-03-08 | $163.00K derived: sum of 3 quarters · filed 2017-03-08 | $1.06M derived: sum of 4 quarters · filed 2017-03-08 | |
| 2014-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-08 | $3.33M derived: sum of 2 quarters · filed 2017-03-08 | $4.24M derived: sum of 3 quarters · filed 2017-03-08 | $4.88M 10-K · filed 2017-03-08 | |
| 2014-09-30 | $2.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $3.21M derived: sum of 2 quarters · filed 2015-11-06 | $3.85M 10-Q · filed 2015-11-06 | $4.38M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-06-30 | $901.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $1.54M 10-Q · filed 2015-08-07 | $2.07M derived: sum of 3 quarters · filed 2016-03-10 | $4.55M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2014-03-31 | $643.00K 10-Q · filed 2015-05-06 | $1.17M derived: sum of 2 quarters · filed 2016-03-10 | $3.65M derived: sum of 3 quarters · filed 2016-03-10 | $4.17M derived: sum of 4 quarters · filed 2016-03-10 | |
| 2013-12-31 | $525.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $3.01M derived: sum of 2 quarters · filed 2016-03-10 | $3.52M derived: sum of 3 quarters · filed 2016-03-10 | $5.52M 10-K · filed 2016-03-10 | |
| 2013-09-30 | $2.48M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $3.00M derived: sum of 2 quarters · filed 2014-11-04 | $5.00M 10-Q · filed 2014-11-04 | $4.58M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $515.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $2.51M 10-Q · filed 2014-08-08 | $2.10M derived: sum of 3 quarters · filed 2015-03-12 | $3.47M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $2.00M 10-Q · filed 2014-05-07 | $1.58M derived: sum of 2 quarters · filed 2015-03-12 | $2.96M derived: sum of 3 quarters · filed 2015-03-12 | $2.71M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | -$417.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $959.00K derived: sum of 2 quarters · filed 2015-03-12 | $713.00K derived: sum of 3 quarters · filed 2015-03-12 | $2.34M 10-K · filed 2015-03-12 | $2.34M 10-K · filed 2013-03-07 |
| 2012-09-30 | $1.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $1.13M derived: sum of 2 quarters · filed 2013-11-06 | $2.75M 10-Q · filed 2013-11-06 | $2.25M derived: sum of 4 quarters · filed 2014-03-12 | |
| 2012-06-30 | -$246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $1.38M 10-Q · filed 2013-08-08 | $873.00K derived: sum of 3 quarters · filed 2014-03-12 | $1.65M derived: sum of 4 quarters · filed 2014-03-12 | |
| 2012-03-31 | $1.62M 10-Q · filed 2013-05-08 | $1.12M derived: sum of 2 quarters · filed 2014-03-12 | $1.89M derived: sum of 3 quarters · filed 2014-03-12 | $1.15M derived: sum of 4 quarters · filed 2014-03-12 | |
| 2011-12-31 | -$505.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $268.00K derived: sum of 2 quarters · filed 2014-03-12 | -$473.00K derived: sum of 3 quarters · filed 2014-03-12 | $2.72M 10-K · filed 2014-03-12 | |
| 2011-09-30 | $773.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $32.00K derived: sum of 2 quarters · filed 2012-11-09 | $3.22M 10-Q · filed 2012-11-09 | $3.19M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-06-30 | -$741.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $2.45M 10-Q · filed 2012-08-08 | $2.42M derived: sum of 3 quarters · filed 2013-03-07 | $2.83M derived: sum of 4 quarters · filed 2013-03-07 | |
| 2011-03-31 | $3.19M 10-Q · filed 2012-05-09 | $3.16M derived: sum of 2 quarters · filed 2013-03-07 | $3.58M derived: sum of 3 quarters · filed 2013-03-07 | ||
| 2010-12-31 | -$33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $386.00K derived: sum of 2 quarters · filed 2013-03-07 | $3.41M 10-K · filed 2013-03-07 | ||
| 2010-09-30 | $419.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $3.44M 10-Q · filed 2011-11-07 | |||
| 2010-06-30 | $3.02M 10-Q · filed 2011-08-08 | ||||
| 2009-12-31 | $313.00K 10-K/A · filed 2012-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |